Institute for Quality and Efficiency in Health Care
The Institute for Quality and Efficiency in Healthcare (IQWiG) (German: Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen) is a German agency responsible for assessing the quality and efficiency of medical treatments, including drugs, non-drug interventions (e.g. surgical procedures), diagnostic and screening methods, and treatment and disease management. IQWiG also supplies health information to patients and the general public.
The organization is independent of the pharmaceutical industry, contracted solely by the Federal Ministry of Health and the Joint Federal Committee.
IQWiG was founded in 2004 under the directorship of Dr Peter Sawicki, who was in September 2010 replaced by Dr Jürgen Windeler. Its deputy director is Dr Stefan Lange.
IQWiG is divided into the following departments, which publish reports:
- Drug Assessment
- Non-Drug Interventions
- Quality of Health Care
- Medical Biometry
- Health Economics
General health information, written in plain language, is additionally produced by a Health Information department.
These departments are also supported by Administration and Communication departments.
Most noticed reportsEdit
Insulin analogues were deemed as not superior to human insulin for the treatment of type I diabetes.
- "Reboxetine for acute treatment of major depression: systematic review and meta-analysis of published and unpublished placebo and selective serotonin reuptake inhibitor controlled trials". British Medical Journal. 341: c4737–c4737. 2010. doi:10.1136/bmj.c4737. PMC 2954275. PMID 20940209.
- Schueler YB; Koesters M; Wieseler B; Grouven U; Kromp M; Kerekes MF; Kreis J; Kaiser T; et al. (2010). "A systematic review of duloxetine and venlafaxine in major depression, including unpublished data". Acta Psychiatrica Scandinavica. 123 (4): 247–265. doi:10.1111/j.1600-0447.2010.01599.x. PMID 20831742.
- Memantine in Alzheimer’s disease: Results of the unpublished studies IE2101 and MEM-MD-22 as well as unpublished responder analyses IQWiG Public release date: 2-Aug-2010
- Long-acting insulin analogues in the treatment of diabetes mellitus type 1 IQWiG Public release date: 19-Apr-2010